Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

Inhibition of soluble epoxide hydrolase alleviates insulin

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

Therapeutic and Prognostic Significance of Arachidonic Acid in

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

Cardiomyocyte-specific disruption of soluble epoxide hydrolase

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

PDF) Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

Inhibition of soluble epoxide hydrolase alleviates insulin

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

Cardiomyocyte-specific disruption of soluble epoxide hydrolase

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

High-fat feeding in cardiomyocyte-restricted PPARδ knockout mice

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against  heart failure via increasing epoxyeicosatrienoic acids - Journal of  Molecular and Cellular Cardiology

A novel soluble epoxide hydrolase vaccine protects murine cardiac